Belatacept in Kidney Transplant Recipients with Preformed Donor Specific Anti-HLA Antibodies: Results of the BELACOR Trial.

被引：0
|
作者：
Leibler, C. [1 ]
Canoui, F. [2 ]
Matignon, M. [1 ]
Rondeau, E. [3 ]
Zarour, A. [2 ]
Durrbach, A. [4 ]
Malard, S. [5 ]
Grimbert, P. [1 ]
机构：
[1] APHP Henri Mondor, Nephrol Transplantat, Creteil, France
[2] APHP Henri Mondor, Publ Hlth, Creteil, France
[3] APHP Tenon, Nephrol Transplantat, Paris, France
[4] APHP Bicetre, Nephrol Transplantat, Le Kremlin Bicetre, France
[5] APHP St Louis, Histocompatibil, Paris, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
121
引用
收藏
页码：293 / 293
页数：1
相关论文
共 50 条
  • [1] The Impact of Belatacept on Anti-HLA Antibodies of Highly Sensitized Kidney Transplant Recipients
    Parsons, R.
    Decker, H.
    Pearson, T.
    Larsen, C.
    Bray, R.
    Gebel, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 426 - 426
  • [2] Anti-HLA antibodies monitoring in kidney transplant recipients: high prevalence of donor specific anti-HLA class II antibodies
    Ares, O. M.
    Ruiz, A. T.
    Tagarro, E. F.
    Samper, R. G.
    Rodriguez, R. G.
    Palop, F. H.
    Valentin, M. A. P.
    Estupinan, R. S.
    Perez, J. C. R.
    Andres, M. D. C.
    IMMUNOLOGY, 2012, 137 : 736 - 737
  • [3] Accelerated Progression of Arteriosclerosis in Kidney Transplant Patients with Preformed Donor Specific Anti-HLA Antibodies
    Hill, G. S.
    Loupy, A.
    Bruneval, P.
    Glotz, D.
    Anglicheau, D.
    Zuber, J.
    Martinez, F.
    Thervet, E.
    Legendre, C.
    Nochy, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 124 - 124
  • [4] Impact of Preformed, Donor-Specific, Anti-HLA Antibodies on Combined Liver Kidney Transplant Outcome
    Mandal, Saptarshi
    Du, Zeying
    Weidner, Jerome
    Ramahi, Sana
    Kunnavakkam, Rangesh
    Te, Helen
    Marino, Susana R.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (03) : 506 - 506
  • [5] Improved detection of donor preformed specific anti-HLA antibodies in kidney transplants recipients by flow cytometry crossmatching
    Fagundes, I.
    Jobim, M.
    Kulzer, A.
    Chamun, B.
    Gamio, F.
    Ewald, G.
    Schlottfeldt, J.
    Oliveira, F.
    Kruger, M.
    Toresan, R.
    Salim, P. H.
    Lindhal, F.
    Jobim, L. F.
    TISSUE ANTIGENS, 2008, 72 (03): : 259 - 260
  • [6] Conversion from Calcineurin Inhibitors to Belatacept in Kidney Recipients with Donor-Specific Anti-HLA Antibodies and Calcineurin Inhibitor Nephrotoxicity Decreases the Pathogenicity of Donor-Specific Anti-HLA Antibodies.
    Louis, K.
    Viglietti, D.
    Pievani, D.
    Aubert, O.
    Glotz, D.
    Legendre, C.
    Zeevi, A.
    Loupy, A.
    Lefaucheur, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 449 - 450
  • [7] CONVERSION FROM CALCINEURIN INHIBITORS TO BELATACEPT IN KIDNEY RECIPIENTS DECREASES THE PATHOGENICITY OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES
    Viglietti, Denis
    Louis, Kevin
    Pievani, Daniele
    Van Huyen, Jean-Paul Duong
    Aubert, Olivier
    Glotz, Denis
    Legendre, Christophe
    Loupy, Alexandre
    Zeevi, Adriana
    Lefaucheur, Carmen
    TRANSPLANT INTERNATIONAL, 2019, 32 : 81 - 81
  • [8] THE ROLE OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN LIVER TRANSPLANT RECIPIENTS
    Uenlue, S.
    Lachmann, N.
    Jara, M.
    Ritschl, P. V.
    Weiss, S.
    Chopra, S.
    Denecke, C.
    Gerlach, U.
    Eurich, D.
    Pratschke, J.
    Oelinger, R.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 12 - 12
  • [9] DONOR SPECIFIC ANTI-HLA ANTIBODIES IN TRANSPLANT GLOMERULOPATHY
    Eng, Hooi Sian
    Bennett, Greg
    Tsiopelas, Eleni
    Chang, Sean
    Bardy, Peter
    Russ, Graeme
    Coates, P. Toby H.
    HUMAN IMMUNOLOGY, 2008, 69 : S109 - S109
  • [10] Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients
    de Sousa, Marcos Vinicius
    Goncalez, Ana Claudia
    Zollner, Ricardo de Lima
    Mazzali, Marilda
    ANNALS OF TRANSPLANTATION, 2018, 23 : 457 - 466
12345